Larvol Delta - ASCO-Issues-First-Living-Guideline-for-Recurrent-Ovarian-Cancer-TreatmentWhat-does-the-guideline-recommend-for-platinumresistant-recurrence

Elahere (mirvetuximab soravtansine-gynx) - AbbVie

Lifyorli (relacorilant) - Corcept Therap

https://www.cancernetwork.com/view/asco-issues-first-living-guideline-for-recurrent-ovarian-cancer-treatment

Aug 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next